GBA BREAK OUT REPORT:: CAN WE TRUST CHINESE COFFEE? LKNCY Company Profile Luckin Coffee Inc. offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China. It offers hot and iced freshly brewed coffee, such as Americano, Latte; specialty coffee products, such as the fruity americano; and tea products, such as the light milk tea series, as well as SOE coffee products, chinese tea-flavored coffee, velvet latte, and coconut milk latte; and pre-made food and beverage items, such as pastries, sandwiches, water, breads, and snacks. In addition, the company through Luckin Coffee Instant brand offers instant coffee, coffee concentrate, coffee beans, drip coffee bags, and coffee capsules and complementary coffee accessories, including thermal tumblers, mugs, pour-over kettles, latte art pitchers, and coffee grinders, as well as inspirational cups through mobile apps and e-commerce platforms. It operates pick-up stores, relax stores, and delivery kitchens under the Luckin brand, as well as Luckin mobile app, Weixin mini-program, and other third-party platforms for third-party payment channels. Further, the company offers technical and consultation services; and manufactures materials for products. Luckin Coffee Inc. was incorporated in 2017 and is headquartered in Xiamen, the People's Republic of China.
Don't know about these Chinese coffee types. I think they gamble too.. But this chart certainly shows a BROS like event shaping up/// Luckin Coffee launches in U.S. rivaling Starbucks, Tim Hortons NewsYesterday, 4:00 PM LKNCY Luckin Coffee Inc. $38.49 0.50(+1.32%)1:00 PM 07/03/25 Pineapple Cobra? yuck/ https://www.youtube.com/shorts/FUZXwnm3W20
Not good/ Boston is where all the smart folks ion biotech are at... Boston’s biotech sector reels due to Trump health policy uncertainty PREMIUM Financial Times•2 hours ago
Here's the Smartest Way to Invest in the S&P 500 in July Key Points Just about any month is a good time to invest in an S&P 500 index fund. Doing so is like betting on the future success of the American economy. Many index funds sport ultra-low fees, too; below are some to consider. So you want to invest in the S&P 500, the index that's comprised of 500 of America's biggest and best companies. That's great! After all, while there are several thousand public companies in the U.S. for investors to choose from, the S&P 500 companies make up around 80% of the value of the whole U.S. stock market. Investing in the S&P 500 is essentially expressing confidence that the U.S. economy will keep growing over time, despite occasional pullbacks. It's a simple, fast, and smart way to invest in the U.S. stock market that doesn't require you to become any kind of investing expert. Van & friend. The smartest way to invest in the S&P 500 in July... The smartest way to invest in the S&P 500 index in July is just to buy SDS ProShares UltraShort S&P500 ETF ETF
On July 3, Bloomberg News reported that AstraZeneca (NASDAQ:AZN) is in discussions with Summit Therapeutics for a licensing agreement concerning an experimental lung cancer drug, with a potential value of up to $15 billion. The proposed deal for the drug, which is known as ivonescimab, could involve an upfront payment of several billion dollars to Summit, in addition to future milestone payments. However, the talks are ongoing and could still fall apart. Summit might even choose to partner with a different company. Neither Summit nor AstraZeneca has officially commented on the report. >>> I think just the fact that talks are going on with such a big player gives us confidence in Summit's lead lung cancer candidate...// >>> Two ways to play it: blindly buy // wait for disappointment but buy anyway that day... Eventually a deal gets done with someone.
Hummmmmmmm. Summit Therapeutics secured the rights to ivonescimab through a separate deal worth up to $5 billion with China-based Akeso in December 2022. Under that agreement, Summit gained exclusive rights to develop and commercialize ivonescimab in the US, Canada, Europe, and Japan, while Akeso (OTC:AKESF) retained rights for other regions, including China. The deal included an upfront payment of $500 million to Akeso and potential regulatory and commercial milestones of up to $4.5 billion. Hold Up. Money would be coming in one door and out another... Maybe not the HR we thought...
Time’s up for roughly 2 million Americans on the cusp of having their Social Security payments slashed in half. And it has nothing to do with the looming shortfall in Social Security's reserves. That’s still eight years down the road. The reduced benefit payments starting this month are how the Social Security Administration (SSA) is attempting to recoup money it overpaid to some Americans. Social Security will withhold 50% of a beneficiary’s monthly check until the sum of their overpayments is reclaimed. The SSA issues nearly $1.4 trillion a year to some 73 million Social Security and SSI recipients. An overpayment can occur when a beneficiary doesn’t update a change in income, for example, or when the SSA incorrectly calculates a person's benefits. The agency is required by law to try to claw back or reclaim money when overpayments occur. “Overpayments should be recouped, but we remain concerned about the impact of any recovery rate on the less financially stable retirees,” Shannon Benton, executive director of the Senior Citizens League, told Yahoo Finance. During the Biden administration, the default withholding rate was dropped to 10% of a beneficiary’s monthly benefit from 100%, dramatically reducing financial hardship on those with overpayments. In March, however, the Trump administration announced that the agency would again withhold 100% of an individual’s Social Security check until all overpaid funds were paid back. After pushback from advocates and seniors, in April, the rate was reduced to 50%, and the agency said it would begin retrieving incorrect payments made between 2015 and 2022, starting in July. It’s still a serious problem for many seniors. “For some retirees, it won't matter if it's 1% or 100%,” Benton said. “Any amount of clawback could be catastrophic.” Improper payments accounted for less than 1% of the total benefits paid during that period, but at the end of fiscal year 2023, SSA had an uncollected overpayment balance of $23 billion, according to an August 2024inspector general’s report. The SSA estimates it made nearly $72 billion in improper payments, most of which were overpayments, from 2015 through 2022. This is tricky. And could be problematic >>>